Figure 1.
Mean weight of participants attending or missing the next visit.
Some patients return after a missed visit. Therefore no change in number of patients at week 28 and 32.
Figure 2.
Analysis of difference in weight loss between placebo and topiramate pooled (96 and 192 mg/day) from baseline to week 60 using different methods.
Figure 3.
Analysis of weight loss over time in topiramate pooled (96 or 192 mg/day) group using different imputation methods.
Figure 4.
Analysis of weight loss over time in the placebo group using different imputation methods.
Table 1.
Percentage weight change from enrolment (- 8 week) to end of treatment (week 60).